FOLH1 and pancreatic adenocarcinoma: The prognostic power of PSMA has been shown in squamous cell carcinoma of the head and neck, osteosarcoma, colorectal cancer, adenocarcinoma of the pancreas, lung cancer and others, demonstrating that PSMA expression appears to reflect prognostically relevant tumour features for several PSMA-expressing tumour entities [53].